239 related articles for article (PubMed ID: 35090172)
1. Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression.
Topfer SK; Feng R; Huang P; Ly LC; Martyn GE; Blobel GA; Weiss MJ; Quinlan KGR; Crossley M
Blood; 2022 Apr; 139(14):2107-2118. PubMed ID: 35090172
[TBL] [Abstract][Full Text] [Related]
2. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M
Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
4. A natural regulatory mutation in the proximal promoter elevates fetal
Martyn GE; Wienert B; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
Blood; 2019 Feb; 133(8):852-856. PubMed ID: 30617196
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.
Ravi NS; Wienert B; Wyman SK; Bell HW; George A; Mahalingam G; Vu JT; Prasad K; Bandlamudi BP; Devaraju N; Rajendiran V; Syedbasha N; Pai AA; Nakamura Y; Kurita R; Narayanasamy M; Balasubramanian P; Thangavel S; Marepally S; Velayudhan SR; Srivastava A; DeWitt MA; Crossley M; Corn JE; Mohankumar KM
Elife; 2022 Feb; 11():. PubMed ID: 35147495
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for human ZBTB7A action at the fetal globin promoter.
Yang Y; Ren R; Ly LC; Horton JR; Li F; Quinlan KGR; Crossley M; Shi Y; Cheng X
Cell Rep; 2021 Sep; 36(13):109759. PubMed ID: 34592153
[TBL] [Abstract][Full Text] [Related]
7. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
[TBL] [Abstract][Full Text] [Related]
8. Original Research: Generation of non-deletional hereditary persistence of fetal hemoglobin β-globin locus yeast artificial chromosome transgenic mouse models: -175 Black HPFH and -195 Brazilian HPFH.
Braghini CA; Costa FC; Fedosyuk H; Neades RY; Novikova LV; Parker MP; Winefield RD; Peterson KR
Exp Biol Med (Maywood); 2016 Apr; 241(7):697-705. PubMed ID: 26946532
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.
Prakobkaew N; Fucharoen S; Fuchareon G; Siriratmanawong N
Eur J Haematol; 2014 Jan; 92(1):73-9. PubMed ID: 24112054
[TBL] [Abstract][Full Text] [Related]
10. Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.
Weber L; Frati G; Felix T; Hardouin G; Casini A; Wollenschlaeger C; Meneghini V; Masson C; De Cian A; Chalumeau A; Mavilio F; Amendola M; Andre-Schmutz I; Cereseto A; El Nemer W; Concordet JP; Giovannangeli C; Cavazzana M; Miccio A
Sci Adv; 2020 Feb; 6(7):. PubMed ID: 32917636
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.
Hariharan P; Sawant M; Gorivale M; Manchanda R; Colah R; Ghosh K; Nadkarni A
Mol Biol Rep; 2017 Oct; 44(5):413-417. PubMed ID: 28879539
[TBL] [Abstract][Full Text] [Related]
12. A functional element necessary for fetal hemoglobin silencing.
Sankaran VG; Xu J; Byron R; Greisman HA; Fisher C; Weatherall DJ; Sabath DE; Groudine M; Orkin SH; Premawardhena A; Bender MA
N Engl J Med; 2011 Sep; 365(9):807-14. PubMed ID: 21879898
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology and hematologic characterization of δβ-thalassemia and hereditary persistence of fetal hemoglobin in 125,661 families of greater Guangzhou area, the metropolis of southern China.
Jiang F; Zuo L; Li D; Li J; Tang X; Chen G; Zhou J; Lu H; Liao C
BMC Med Genet; 2020 Feb; 21(1):43. PubMed ID: 32111191
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel candidate genes for globin regulation in erythroid cells containing large deletions of the human beta-globin gene cluster.
de Andrade TG; Peterson KR; Cunha AF; Moreira LS; Fattori A; Saad ST; Costa FF
Blood Cells Mol Dis; 2006; 37(2):82-90. PubMed ID: 16952470
[TBL] [Abstract][Full Text] [Related]
15. LRF Promotes Indirectly Advantageous Chromatin Conformation via
Chondrou V; Shaukat AN; Psarias G; Athanasopoulou K; Iliopoulou E; Damanaki A; Stathopoulos C; Sgourou A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806029
[TBL] [Abstract][Full Text] [Related]
16. Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies.
Paschoudi K; Yannaki E; Psatha N
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298481
[TBL] [Abstract][Full Text] [Related]
17. Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
Liu N; Hargreaves VV; Zhu Q; Kurland JV; Hong J; Kim W; Sher F; Macias-Trevino C; Rogers JM; Kurita R; Nakamura Y; Yuan GC; Bauer DE; Xu J; Bulyk ML; Orkin SH
Cell; 2018 Apr; 173(2):430-442.e17. PubMed ID: 29606353
[TBL] [Abstract][Full Text] [Related]
18. 3'HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression.
Himadewi P; Wang XQD; Feng F; Gore H; Liu Y; Yu L; Kurita R; Nakamura Y; Pfeifer GP; Liu J; Zhang X
Elife; 2021 Sep; 10():. PubMed ID: 34585664
[TBL] [Abstract][Full Text] [Related]
19. Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus.
Antoniani C; Meneghini V; Lattanzi A; Felix T; Romano O; Magrin E; Weber L; Pavani G; El Hoss S; Kurita R; Nakamura Y; Cradick TJ; Lundberg AS; Porteus M; Amendola M; El Nemer W; Cavazzana M; Mavilio F; Miccio A
Blood; 2018 Apr; 131(17):1960-1973. PubMed ID: 29519807
[TBL] [Abstract][Full Text] [Related]
20. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]